CYP19A1 and hypogonadism: In obese men, due to the overexpression of aromatase in adipose tissue, obese individuals exhibit increased concentrations of estrogen, which plays an important role in the development of hypogonadism through a negative feedback loop in which men exhibit hypogonadotropic symptoms (31).